These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30600987)
1. In Situ Characterization of Protein Corona Formation on Silica Microparticles Using Confocal Laser Scanning Microscopy Combined with Microfluidics. Weiss ACG; Krüger K; Besford QA; Schlenk M; Kempe K; Förster S; Caruso F ACS Appl Mater Interfaces; 2019 Jan; 11(2):2459-2469. PubMed ID: 30600987 [TBL] [Abstract][Full Text] [Related]
2. Microfluidic Examination of the "Hard" Biomolecular Corona Formed on Engineered Particles in Different Biological Milieu. Weiss ACG; Kempe K; Förster S; Caruso F Biomacromolecules; 2018 Jul; 19(7):2580-2594. PubMed ID: 29668268 [TBL] [Abstract][Full Text] [Related]
3. Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles. Weiss ACG; Kelly HG; Faria M; Besford QA; Wheatley AK; Ang CS; Crampin EJ; Caruso F; Kent SJ ACS Nano; 2019 May; 13(5):4980-4991. PubMed ID: 30998312 [TBL] [Abstract][Full Text] [Related]
4. Super-Resolution Microscopy Unveils Dynamic Heterogeneities in Nanoparticle Protein Corona. Feiner-Gracia N; Beck M; Pujals S; Tosi S; Mandal T; Buske C; Linden M; Albertazzi L Small; 2017 Nov; 13(41):. PubMed ID: 28922574 [TBL] [Abstract][Full Text] [Related]
5. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins. Weber C; Simon J; Mailänder V; Morsbach S; Landfester K Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856 [TBL] [Abstract][Full Text] [Related]
6. Protein-Nanoparticle Interactions: What Are the Protein-Corona Thickness and Organization? Marichal L; Giraudon-Colas G; Cousin F; Thill A; Labarre J; Boulard Y; Aude JC; Pin S; Renault JP Langmuir; 2019 Aug; 35(33):10831-10837. PubMed ID: 31333024 [TBL] [Abstract][Full Text] [Related]
7. Dual Functionalization of Nanoparticles for Generating Corona-Free and Noncytotoxic Silica Nanoparticles. Affonso de Oliveira JF; Scheffer FR; Landis RF; Teixeira Neto É; Rotello VM; Cardoso MB ACS Appl Mater Interfaces; 2018 Dec; 10(49):41917-41923. PubMed ID: 30426737 [TBL] [Abstract][Full Text] [Related]
8. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. Mirshafiee V; Kim R; Mahmoudi M; Kraft ML Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610 [TBL] [Abstract][Full Text] [Related]
9. On the growth of the soft and hard protein corona of mesoporous silica particles with varying morphology. Kuschnerus I; Giri K; Ruan J; Huang Y; Bedford N; Garcia-Bennett A J Colloid Interface Sci; 2022 Apr; 612():467-478. PubMed ID: 34999551 [TBL] [Abstract][Full Text] [Related]
10. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy. Shang L; Nienhaus GU Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686 [TBL] [Abstract][Full Text] [Related]
11. Beyond Unpredictability: The Importance of Reproducibility in Understanding the Protein Corona of Nanoparticles. Galmarini S; Hanusch U; Giraud M; Cayla N; Chiappe D; von Moos N; Hofmann H; Maurizi L Bioconjug Chem; 2018 Oct; 29(10):3385-3393. PubMed ID: 30141619 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-protein complexes mimicking corona formation in ocular environment. Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757 [TBL] [Abstract][Full Text] [Related]
13. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles. Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954 [TBL] [Abstract][Full Text] [Related]
14. Multicolor Super-Resolution Microscopy of Protein Corona on Single Nanoparticles. Wang Y; Soto Rodriguez PED; Woythe L; Sánchez S; Samitier J; Zijlstra P; Albertazzi L ACS Appl Mater Interfaces; 2022 Aug; 14(33):37345-37355. PubMed ID: 35961006 [TBL] [Abstract][Full Text] [Related]
15. How Corona Formation Impacts Nanomaterials as Drug Carriers. Gupta MN; Roy I Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673 [TBL] [Abstract][Full Text] [Related]
16. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312 [TBL] [Abstract][Full Text] [Related]
17. Real-Time Optical Tracking of Protein Corona Formation on Single Nanoparticles in Serum. Dolci M; Wang Y; Nooteboom SW; Soto Rodriguez PED; Sánchez S; Albertazzi L; Zijlstra P ACS Nano; 2023 Oct; 17(20):20167-20178. PubMed ID: 37802067 [TBL] [Abstract][Full Text] [Related]
18. The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome. Pisani C; Gaillard JC; Odorico M; Nyalosaso JL; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Armengaud J; Prat O Nanoscale; 2017 Feb; 9(5):1840-1851. PubMed ID: 27858044 [TBL] [Abstract][Full Text] [Related]
19. Protein Adsorption From Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity. Clemments AM; Botella P; Landry CC ACS Appl Mater Interfaces; 2015 Oct; 7(39):21682-9. PubMed ID: 26371804 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas. Dai Q; Yan Y; Ang CS; Kempe K; Kamphuis MM; Dodds SJ; Caruso F ACS Nano; 2015 Mar; 9(3):2876-85. PubMed ID: 25712076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]